Preliminary exploratory signals are consistent with potential modulation of neuroplasticity (BDNF) and selected psychosocial outcomes (anxiety, depression, sleep quality, physical activity), supporting the biological plausibility of this approach. The gene discussed is BDNF; the disease is major depressive disorder.